| Bioactivity | DSPE-PEG-Folate (Mw 3350) is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research[1][2][3]. |
| Name | DSPE-PEG-Folate |
| CAS | 1236288-25-7 |
| Formula | C65H114N11O16P |
| Molar Mass | 3400.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Werner ME, et, al. Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials. 2011 Nov;32(33):8548-54. [2]. Li Y, et, al. Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release. ACS Appl Mater Interfaces. 2015 Aug 19;7(32):17573-81. [3]. Patlolla RR, et al. Folate-targeted etoposide-encapsulated lipid nanospheres. J Drug Target. 2008 May;16(4):269-75. |
DSPE-PEG-Folate
CAS: 1236288-25-7 F: C65H114N11O16P W: 3400.00
DSPE-PEG-Folate (Mw 3350) is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.